Portfolio - Green
 


SAIL
believes that innovation in every category of cleantech
is compelling and can often drive exciting, high-growth business models. Green Innovation refers to all other categories of cleantech, some of which include agriculture, material science, medicine, sustainable building and pollution control. SAIL evaluates investments in these categories when they offer particularly compelling value propositions and return potential. 

 


Formerly known as the Cleantech Venture Network, Cleantech Group LLC is the global leader in the development of the cleantech category, fostering growth through information products, world class research and the highest caliber industry connections. The Cleantech Group is credited with originating the term cleantech, and owns it as a registered trademark. Membership in the Cleantech Network is open to cleantech investors, entrepreneurs, enterprises and service providers who benefit from access to proprietary cleantech research & data, news, innovation pipeline for entrepreneurs seeking capital, an executive search mechanism, the Cleantech Index® of publicly traded companies and a cleantech provider database for enterprises. The company also has global operations and hosts a series of cleantech forums around the world bringing the cleantech industry together to foster new innovation, education and networking in the sector.


www.cleantech.com

CNS is the first company to develop and market a neurophysiological bio-marker system which can objectively measure the physiological effects of psychiatric drugs on humans. Referenced-EEG® is a patented (issued 2003 and 2007) proprietary technology of CNS that employs commonly used digital electroencephalography (EEG) in conjunction with a normative database and a proprietary clinical (symptomatic) database to identify abnormal patient physiology. Appropriate medications are then statistically selected specifically to normalize discovered abnormalities. In a series of clinical trials on patients who suffered for years without responding to treatment, physicians guided over 75% of them to medications that worked using Referenced-EEG® technology. CNS is the first company to discover the basis for matching mental and addiction patient physiology to the outcome of treatment, thereby fundamentally altering the treatment of psychiatric illness.


www.cnsresponse.com

Activeion is the developer of the ActiveionPro, a hand-held device that has the proven ability by ionization to turn ordinary tap water into a powerful cleansing and disinfectant agent that returns back to tap water after the job is done. This technology allows the removal of dangerous chemicals used in cleaning products from the home and office as well as schools. Converting to just one ActiveionPro for general-purpose cleaning in commercial applications is equivalent to saving 93 gallons of gasoline and two barrels of oil; and for every two units deployed for cleaning, one metric ton of coal is offset.

 


www.activeion.com